The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis-Reference-Cited by-同舟云学术

The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis

Published:2008-12 Issue:11-12 Volume:28 Page:1287-1296
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

BUCKLAND A.,BODGER K.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2008.03856.x/fullpdf

Reference28 articles.

1. Guidelines for the management of inflammatory bowel diseases in adults;Carter;Gut,2004

2. Regular review: ulcerative colitis;Ghosh;BMJ,2000

3. Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: the ASCEND I trial;Hanauer;Can J Gastroenterol,2007

4. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial;Hanauer;Am J Gastroenterol,2005

5. Modified-release oral mesalazine 4.8 g/day (800 mg tablet) versus 2.4 g/day (400 mg tablet) for treatment of moderately active ulcerative colitis: combined analysis of two randomised, double-blind controlled trials;Hanauer;Gastroenterology,2005

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical management of mild-to-moderate ulcerative colitis: an international expert consensus;Expert Review of Gastroenterology & Hepatology;2024-08-02

2. Alleviative effects of sulfated polysaccharide from Ishige Okamurae against DSS-induced ulcerative colitis via inhibiting inflammation and modulating gut microbiota;International Journal of Biological Macromolecules;2024-05

3. Management and treatment optimization of patients with mild to moderate ulcerative colitis;Expert Review of Clinical Immunology;2023-12-07

4. Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus;Journal of Clinical Medicine;2023-11-04

5. Evaluation of Anti-inflammatory Effects of Polysaccharide Derived from Plantago ovata Husk on Trinitro Benzenesulfonic Acid-induced Ulcerative Colitis in Mice;Indian Journal of Pharmaceutical Education and Research;2023-10-04